vulcanSpot

vulcanSpot prioritizes therapeutic vulnerabilities in cancer by integrating genome-wide screening experiments and applying a weighted scoring system to drug-gene relationships to identify candidate targets, cancer-specific gene dependencies, and drug repositioning opportunities, including genes considered undruggable.

Key Features:

• Integration of Genome-Wide Data: Integrates genome-wide screening experiments to map genetic alterations and tumor-specific gene dependencies.
• Prioritization of Therapeutic Options: Applies a weighted scoring system to prioritize drugs based on known drug-gene relationships and to support drug repositioning strategies.
• Exploitation of Cancer-Specific Vulnerabilities: Identifies cancer-specific gene dependencies, including targets often considered undruggable, to expand potential therapeutic options.

Scientific Applications:

• Oncology research: Identification and prioritization of novel therapeutic targets from genome-wide dependency data.
• Precision/personalized medicine: Informing patient-stratified treatment strategies based on tumor-specific vulnerabilities.
• Drug repositioning: Recommending existing drugs for new cancer indications by prioritizing drug-gene interactions.

Methodology:

Integrates data from genome-wide screening experiments, applies a weighted scoring system to known drug-gene interactions for prioritization, and identifies cancer-specific gene dependencies as candidate therapeutic targets.